From over-paid executives and first-class travel, to marketing partnerships that include dangerous and carcinogenic products, from “awareness” campaigns that don’t seem to take into account that we ALL know about brest cancer, to a paltry allocation to actual RESEARCH “…for a CURE” (25% according to Komen, under 17% when you take out the overhead), it is high time that this organization, that is supported both by donors AND American tax-payers, come under the spotlight. If you KNOWINGLY agree with their priorities, then terrific…but most have no clue how little “…for the cure” happens at Komen. It’s time for transparency!
You’ve heard it all from me before, but today’s headline that Komen President Liz Thompson is leaving and that Founder Nancy Brinker is shifting to a new strategic planning role may be a step in the right direction, but it doesn’t get us where we need to be. In addition to leadership change, we need still need TRANSPARENCY. Here’s the story in USA Today: Komen president resigning, founder shifting roles
Here was my comment on the USA Today site:
Let’s hope this is enough, but I’m not yet convinced. Komen, of course, has the right to distribute funds as they see fit and in accordance with the organizations priorities. FAIRLY. When they create rules for one funded agency that don’t apply to others, that’s not okay. When they change the rules of the games and pull back funding that was already allocated, that’s also not okay. Komen knew the Planned Parenthood agenda when they initially allocated funds, and designated their use by Planned Parenthood accordingly. As a public, tax-exempt non-profit, what they do NOT have the right to is to mislead the public. Defunding Planned Parenthood was simply the one act that shed light on the reality of what Komen does the public’s generosity.